MyAverix Finance
HK · Healthcare
Purapharm Corp Ltd (1498)
Drug Manufacturers - Specialty & Generic
Purapharm Corp Ltd (1498) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $160.52M, P/E ratio is 18.00, net margin is -10.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1498
Purapharm Corp Ltd (1498) — FAQ
What is Purapharm Corp Ltd's market cap?
Purapharm Corp Ltd (1498) has a reported market cap of $160.52M (data as of 2026-05-21).
What is 1498's P/E ratio?
The price-to-earnings (P/E) ratio for Purapharm Corp Ltd (1498) is 18.00 (data as of 2026-05-21).
Does Purapharm Corp Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Purapharm Corp Ltd (1498). Check the MyAverix Finance app for the latest dividend data.
What sector is Purapharm Corp Ltd in?
Purapharm Corp Ltd (1498) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 1498 listed on?
1498 is listed on HK.
What is Purapharm Corp Ltd's net margin?
Purapharm Corp Ltd (1498) reports a net margin of -10.5% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.